ICO: Regulatory sandbox report Novartis Pharmaceuticals UK Ltd

“The latest Sandbox report is from medicines company Novartis, which uses innovative science and digital technologies to help transform patient care and improve their experiences and outcomes.

When Novartis entered the Sandbox in July 2019 the original vision was for a voice-enabled web portal allowing patients to fill in health questionnaires from home – retaining a high standard of care but reducing unnecessary face to face appointments.

The ‘Digital Solution’ was designed to allow clinicians to draw upon the data provided online by patients, examine any changes to their patient’s condition and allow prioritisation of patients who need to be seen more urgently in clinic. Engaging with patients from their perspective remotely, allows for better clinical decision-making and less footfall in clinics.” [..]